Rekvina Laboratories P/E Ratio
Rekvina Laboratories (VINRKLB) P/E ratio is not applicable — EPS (TTM) ₹-0.42. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-0.42
Healthcare Peers with Valid P/E Ratios — VINRKLB Comparison
Healthcare sector average P/E 55.48, median 31.02 — VINRKLB excluded (negative EPS).
Sector Average PE
55.48
Sector Median PE
31.02
Lowest PE
2.86
Profitable Companies
196
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.29 | ₹53 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.08 | ₹65 | Low |
| Shelter Pharma | SHELTER | 4.85 | ₹44 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| JFL Life Sciences | JFLLIFE | 6.44 | ₹86 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 7.11 | ₹51 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see VINRKLB share price.
- Read VINRKLB dividend growth for the complete payout history and dividend yield track record.
- See VINRKLB price to book ratio to compare market price against book value per share.